Page 83 - MemoriaES-Eng

www.ciberes.org

• l-c Jl, H S, P-r F, r cM, e coPd A .
Most relevant óPeZAMPoSArtloZoodrígueZoBertSuroPeAnuditteAM
European COPD Audit: design, organisation of work and methodology.Eur Respir J.
scientific 2013 Feb;41(2):270-6.

articles
• roBertS cM, loPeZ-cAMPoS Jl, PoZo-rodrígueZ F, HArtl S, euroPeAn coPd Audit teAM. Eu-
ropean hospital adherence to GOLD recommendations for chronic obstructive pulmo-

nary disease (COPD) exacerbation admissions.Thorax. 2013 Dec;68(12):1169-71.

• MArtíneZ-gArcíA MA, cAPote F, cAMPoS-rodrígueZ F, lloBereS P, díAZ de AtAuri MJ, SoMoZA
M, M JF, g M, S l, .. Effect of CPAP on blood pressure in patients
ASAonZáleZAcriStAnet Al
with obstructive sleep apnea and resistant hypertension: the HIPARCO randomized
clinical trial.JAMA-J AM MED ASSOC. 2013;(310):2407-15.

• o ru, r-P r. Early stage non-small-cell lung cancer: surgi-
SArogiAgBonAMiortA
cal implications of the new adenocarcinoma classification.J Thorac Oncol. 2013
May;8(5):e45-6.

• S g, g MA, A i, c d, d c, g A. Updated clini-
iMonneAuAtZouliSdAtiAelerMAJerentonHoFrAni
cal classification of pulmonary hypertension.J Am Coll Cardiol. 2013 Dec 24;62(25

Suppl):D34-41.

Highlights
1. Participation in the construction of Strategic Research Projects of the PCI to 3
years in the thematic areas of COPD, cancer and pulmonary hypertension:

• Corporate Research Programme in Chronic Obstructive Pulmonary Disease

(COPD).

• Corporate Research Programme Lung Cancer: Molecular staging of lung cancer
stage I / IIp .

• Corporate Research Programme CIBERES Pulmonary Hypertension.

2. Consolidation of a hospital in COPD research network with the participation of all

the Spanish regions (CCAA):

• DELICATO Project: Design and Local Implementation of clinical audits in differ-

ents types of old (fragile COPD)
•
Advanced Spanish cohort of COPD (CEPA).

- CEPA, Subproject 1: Annual incidence and spatial distribution of mortality.
Longitudinal study of a cohort of patients with Severe COPD.

- CEPA, Subproject 2: Phenotypic characterization and clinical evolution to three

years .

- CEPA, Subproject 3: inflammasome comorbidity and clinical course.

• European ERS COPD AUDIT.

• Project AUDIPOC Spain.

3. Coordination and analysis of the data from the first European audit of COPD exac- 13
erbations (European ERS COPD Audit) : Members of the Steering Group and Data 20
T
Analysis Team.
OR
P
4. Contribution to 2016 TNM Spanish record and the tissues samples repository: RE
Retrospective cohort of lung cancer (GCCP-II/IASLC).
L
A
5. Contribution to the Spanish Registry of Pulmonary Hypertension: REHAP.
NU
N
6. Coordination of SEPAR normatives: Spirometry and Nonspecific bronchial hyper- A
S /
responsiveness in Asthma.
E
ER
7. Coordination of the SEPAR normative for management of solitary pulmonary B
CI
nodules.

83